Coport 25 mg (Tablet)
Medicine Details
| Category | Details |
|---|---|
| Generic | Empagliflozin |
| Company | Aci limited |
| Also available as |
Indications
- Adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
- To reduce the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and established cardiovascular disease
Pharmacology
Empagliflozin is a sodium glucose co-transporter-2 (SGLT-2) inhibitor. It reduces renal absorption and lowers the renal threshold for glucose, resulting in increased glucose excretion. It contributes to reduced hyperglycemia, weight loss, and reduced blood pressure.
Dosage & Administration
Recommended dose of Empagliflozin is 10 mg once daily, taken in the morning, with or without food. Dose may be increased to 25 mg once daily in patients tolerating Empagliflozin.
Drug Interaction
- Diuretics
- Insulin or Insulin Secretagogues
- Positive Urine Glucose Test
- Interference with 1,5-anhydroglucitol (1,5-AG) Assay
Contraindications
Contraindicated in patients with history of serious hypersensitivity reaction to Empagliflozin or any of its ingredients, severe renal impairment, end-stage renal disease, or dialysis
Side Effects
- Urinary tract infections
- Female genital mycotic infections
- Dehydration
- Hypotension
- Weakness
- Dizziness
- Increased thirstiness
Pregnancy & Lactation
No adequate and well-controlled studies of Empagliflozin in pregnant women. Should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Not recommended when breastfeeding
Precautions & Warnings
Assessment of renal function is recommended prior to initiation of Empagliflozin and periodically thereafter
Overdose Effects
Usual supportive measures should be employed. Removal of Coport by hemodialysis has not been studied.
Therapeutic Class
Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors
Storage Conditions
Keep in a cool & dry place (below 30° C), protected from light & moisture. Keep out of the reach of children
Chemical Structure
- Molecular Formula: C23H27ClO7
- Chemical Structure: https://medex.com.bd/storage/res/g-res-1275-empagliflozin-chemical-structure-Z3X0mrA6UvgM682Jgp8K.svg
Common Questions
- What is Coport 25 mg Tablet?
- What is Coport 25 mg Tablet used for?
- Are there any pregnancy warnings?
- Are there any breast-feeding warnings?
- Does this affect kidney function?
- Does this affect liver function?
- Quick Tips